Inicio | Buscar

Buscar

Resultados de la búsqueda

Vaccine HER1 / VSSP for prostate cancer, head and neck carcinoma and advanced colon cancer . Phase I

... 2nd Degree Specialist in Oncology Affiliation:  ... Havana, National Institute of Oncology and Radiobiology, Braulio Fernandez Mestre, MD. 1 st degree in ...

Clinical Trials - CIM - 03/11/2017 - 10:38am

Vacuna HER1/VSSP para cancer de próstata, carcinoma de cabeza y cuello y cancer de colon avanzados. Fase I

... and Rosenberg's Cancer: Principles & Practice of Oncology. Lippincott Williams&Wilki; Edición: 10th revised ... growth factor receptor in advanced gastric cancer. Oncology 1992;49:157-61. 116. Umekita Y, Ohi Y, Sagara Y, Yoshida H. ... TS, Rosenberg SA: Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2011, pp ...

Ensayos Clínicos - CIM - 03/11/2017 - 10:37am

EC122 HER-1 Próstata Fase I

... growth factor receptor in advanced gastric cancer. Oncology 1992;49:157-61. 79. Umekita Y, Ohi Y, Sagara Y, Yoshida H. ...

Ensayos Clínicos - CIM - 26/09/2017 - 11:26am

CIMAbior® in CD20-positive B-cell Non-Hodgkin Lymphoma

... Second degree specialist in Oncology Affiliation:  ... Irene Álvarez Montane, MD, first degree specialist in Oncology Holguín. Lucia ...

Clinical Trials - CIM - 05/09/2017 - 11:14am

NGcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III.

... 1st degree specialist in oncology Affiliation:  ... Dra. Ana de la Torre Santos. 2nd degree specialist in oncology Holguin, Vladimir ...

Clinical Trials - CIM - 07/07/2017 - 10:36am

Use of h-R3 monoclonal antibody and radiotherapy to treat patients with advanced epithelial head and neck tumors.

... 2nd degree specialist in oncology Affiliation:  National Institute of Oncology and Radiobiology Postal ...

Clinical Trials - CIM - 05/07/2017 - 8:26am

99mtc-marked 14f7 MAb in colon/rectum tumor, Phase II

... 1st degree specialist in oncology Affiliation:  ...

Clinical Trials - CIM - 04/07/2017 - 4:33pm

NGcGM3/VSSP/Montanide ISA 51 vaccine in metastatic breast cancer. Phase II

... 2nd degree specialist in oncology Affiliation:  ... Havana, National Institute of Oncology and Radiobiology (INOR), Ronald Rodríguez Diaz, MD. 2nd degree ...

Clinical Trials - CIM - 04/07/2017 - 4:07pm

Advanced breast cancer treatment with hR3 monoclonal antibody combined with doxorubicin and cyclophosphamide, phase I.

... 2nd degree specialist in oncology Affiliation:  ...

Clinical Trials - CIM - 23/06/2017 - 4:50pm

Clinical trial, phase II: Evaluation of TheraCIM hR3 MaB combined with chemo- and radio-therapy to treat patients with epithelial tumors in neck of the uterus, stage III.

... 2nd degree specialist in oncology. Affiliation:  National Institute of Oncology and Radiobiology Postal ...

Clinical Trials - CIM - 19/06/2017 - 11:19am